Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 9 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000932 | P-body | 5 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0035770 | ribonucleoprotein granule | 3 | 1 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990124 | messenger ribonucleoprotein complex | 3 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Related structures:
AlphaFold database: A4HEG4
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0033962 | P-body assembly | 7 | 1 |
GO:0034063 | stress granule assembly | 7 | 1 |
GO:0070925 | organelle assembly | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0140694 | non-membrane-bounded organelle assembly | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0003729 | mRNA binding | 5 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 143 | 145 | PF00675 | 0.604 |
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.588 |
CLV_NRD_NRD_1 | 262 | 264 | PF00675 | 0.650 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.614 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.359 |
CLV_PCSK_KEX2_1 | 143 | 145 | PF00082 | 0.604 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.614 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.321 |
DOC_USP7_MATH_1 | 111 | 115 | PF00917 | 0.788 |
DOC_USP7_MATH_1 | 116 | 120 | PF00917 | 0.554 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.520 |
DOC_USP7_UBL2_3 | 228 | 232 | PF12436 | 0.524 |
DOC_USP7_UBL2_3 | 236 | 240 | PF12436 | 0.489 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.679 |
LIG_14-3-3_CanoR_1 | 123 | 129 | PF00244 | 0.714 |
LIG_APCC_ABBA_1 | 74 | 79 | PF00400 | 0.496 |
LIG_BRCT_BRCA1_1 | 124 | 128 | PF00533 | 0.643 |
LIG_BRCT_BRCA1_1 | 240 | 244 | PF00533 | 0.515 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.491 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.575 |
LIG_FHA_2 | 187 | 193 | PF00498 | 0.559 |
LIG_LIR_Gen_1 | 241 | 250 | PF02991 | 0.509 |
LIG_LIR_Gen_1 | 58 | 66 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 241 | 247 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.465 |
LIG_MLH1_MIPbox_1 | 240 | 244 | PF16413 | 0.515 |
LIG_Pex14_2 | 204 | 208 | PF04695 | 0.511 |
LIG_SH2_SRC | 129 | 132 | PF00017 | 0.722 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.704 |
LIG_SUMO_SIM_par_1 | 28 | 36 | PF11976 | 0.472 |
MOD_CDK_SPxxK_3 | 79 | 86 | PF00069 | 0.681 |
MOD_CK1_1 | 114 | 120 | PF00069 | 0.777 |
MOD_CK1_1 | 133 | 139 | PF00069 | 0.625 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.559 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.559 |
MOD_CK2_1 | 219 | 225 | PF00069 | 0.543 |
MOD_Cter_Amidation | 44 | 47 | PF01082 | 0.359 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.646 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.605 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.642 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.688 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.682 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.625 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.543 |
MOD_GSK3_1 | 269 | 276 | PF00069 | 0.596 |
MOD_N-GLC_1 | 159 | 164 | PF02516 | 0.755 |
MOD_NEK2_1 | 243 | 248 | PF00069 | 0.591 |
MOD_NEK2_1 | 274 | 279 | PF00069 | 0.620 |
MOD_NEK2_2 | 124 | 129 | PF00069 | 0.668 |
MOD_PKA_1 | 219 | 225 | PF00069 | 0.515 |
MOD_PKA_2 | 122 | 128 | PF00069 | 0.810 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.748 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.484 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.508 |
MOD_Plk_1 | 238 | 244 | PF00069 | 0.554 |
MOD_Plk_1 | 29 | 35 | PF00069 | 0.496 |
MOD_Plk_1 | 72 | 78 | PF00069 | 0.478 |
MOD_Plk_2-3 | 239 | 245 | PF00069 | 0.531 |
MOD_Plk_4 | 239 | 245 | PF00069 | 0.531 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.478 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.679 |
MOD_SUMO_rev_2 | 186 | 196 | PF00179 | 0.628 |
MOD_SUMO_rev_2 | 215 | 222 | PF00179 | 0.491 |
MOD_SUMO_rev_2 | 225 | 233 | PF00179 | 0.495 |
MOD_SUMO_rev_2 | 69 | 74 | PF00179 | 0.521 |
TRG_ER_diArg_1 | 180 | 182 | PF00400 | 0.612 |
TRG_ER_diArg_1 | 281 | 283 | PF00400 | 0.592 |
TRG_ER_diArg_1 | 288 | 291 | PF00400 | 0.615 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCC4 | Leptomonas seymouri | 72% | 100% |
A0A1X0P4R0 | Trypanosomatidae | 48% | 100% |
A0A3Q8IGG5 | Leishmania donovani | 81% | 99% |
A0A3R7KUL5 | Trypanosoma rangeli | 45% | 100% |
A4I195 | Leishmania infantum | 81% | 99% |
D0A5I6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AXD1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 83% | 100% |
P45978 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 84% |
Q4QA41 | Leishmania major | 86% | 100% |
Q9BX40 | Homo sapiens | 31% | 76% |
V5BN65 | Trypanosoma cruzi | 47% | 91% |